| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 499.40M | 485.80M | 388.80M | 368.90M | 309.00M | 90.60M |
| Gross Profit | 74.00M | 229.50M | 181.50M | 172.80M | 140.90M | -14.60M |
| EBITDA | 86.00M | 80.20M | 63.70M | 76.90M | 82.60M | -2.70M |
| Net Income | 11.50M | 9.80M | 11.10M | 29.70M | 34.40M | -38.30M |
Balance Sheet | ||||||
| Total Assets | 1.31B | 1.31B | 1.35B | 1.05B | 1.06B | 997.50M |
| Cash, Cash Equivalents and Short-Term Investments | 12.10M | 7.50M | 16.90M | 10.70M | 34.00M | 4.70M |
| Total Debt | 320.60M | 343.80M | 376.50M | 175.90M | 207.80M | 253.40M |
| Total Liabilities | 519.70M | 539.90M | 578.00M | 329.70M | 362.20M | 352.10M |
| Stockholders Equity | 786.50M | 771.80M | 771.60M | 724.20M | 699.70M | 645.40M |
Cash Flow | ||||||
| Free Cash Flow | 51.80M | 51.30M | 24.90M | 42.70M | 65.00M | -42.10M |
| Operating Cash Flow | 89.70M | 98.30M | 73.40M | 82.90M | 101.90M | -23.00M |
| Investing Cash Flow | -35.90M | -37.90M | -199.60M | -52.30M | -14.10M | -18.70M |
| Financing Cash Flow | -41.80M | -73.10M | 132.40M | -53.90M | -58.50M | 45.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £361.99M | 5.12 | 4.99% | 2.81% | 6.94% | 9.99% | |
76 Outperform | £8.78M | 2.95 | 10.75% | 1.25% | 2.76% | 40.57% | |
67 Neutral | £461.36M | 5.72 | 1.48% | 3.20% | 12.91% | -13.62% | |
66 Neutral | £356.30M | 1.13 | 9.75% | ― | -0.08% | ― | |
66 Neutral | £1.57B | 8.30 | 6.46% | ― | 3.87% | 18.31% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £631.18M | 8.99 | 15.81% | 1.50% | 4.52% | 50.39% |